Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
基本信息
- 批准号:8530189
- 负责人:
- 金额:$ 9.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Stanford Medicine X is a conference dedicated to innovation and the application of emerging technology to improve medicine and health care. One central aspect of innovation at the core of the mission of our conference is to re-engineer the entire system of research and care of patients with chronic disease. Where our current system might represent an upside-down pyramid where knowledge and innovation is expected to spring up from the top of a rigid hierarchy, with highly specialized academics and practitioners
at the top, and eventually trickle down to patients, our hypothesis is that it makes sense for knowledge to derive from the real experts: patients and their caregivers. Therefore, we believe that there can be a new approach to an academic conference that places the patient at the center of discussion and that will unite all healthcare stakeholders- patients, healthcare professionals, technologists, and researchers-together to help solve health care issues from a patient centered perspective. There is no other academic conference dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient-centered perspective. This proposal seeks funding through the AHRQ R13 grant mechanism to support the conference meetings in 2012, 2013, and 2014. The sole PI for the conference outlined in this proposal is Larry Chu, MD, MS, head of the Anesthesia Informatics and Media (AIM) Lab at Stanford, Associate Professor of Anesthesia, and Organizing Chair for the successful Medicine 2.0 Summit and 4th World Congress at Stanford. Stanford Medicine X will convene for three days annually in September at the Li Ka Shing Center for Learning on the Stanford campus. The objectives of the Medicine X are: 1. To advance understanding of how innovative technologies have the potential to improve patient care and ease the burden of disease from a patient-centered perspective, including tools to empower patients to be involved in their own care. 2. To provide a forum concentrated on uniting stakeholders in health care for opportunities to network and collaborate in innovative, interdisciplinary research and/or technology solutions. 3. To provide education in major areas relevant to emerging technology and their application to clinical medicine. 4. To integrate the patient voice and patient-centered design into the use of emerging technologies to improve health care. 5. To identify those measureable outcomes that are most meaningful to patients and to bring researchers closer to understanding how to incorporate patient-centered design and outcomes into their research. The meeting will be one of the major venues for researchers in the realm of emerging technology and medicine to present and publish their work and to network with a diverse audience of health care providers, patients, technologists, and academicians. Conference proceedings will be published in the official open access conference journals: Journal of Visualized Experiments (JoVE) and Public Library of Science (PLoS ONE). The location of Medicine X at the Stanford School of Medicine allows attendees the access to a breadth of experts and an unmatched number of technologists and health start-ups based in the Silicon Valley.
描述(由申请人提供):斯坦福医学X是一个致力于创新和应用新兴技术来改善医学和卫生保健的会议。创新的一个核心方面是我们会议的核心使命是重新设计整个慢性疾病患者的研究和护理系统。我们目前的体系可能代表一个倒置的金字塔,在那里,知识和创新被期望从严格的等级制度的顶端涌现出来,有高度专业化的学者和实践者
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE F CHU其他文献
LAWRENCE F CHU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE F CHU', 18)}}的其他基金
Understanding the Effects of Chronic Opioids Therapy in Humans
了解慢性阿片类药物治疗对人类的影响
- 批准号:
8636421 - 财政年份:2013
- 资助金额:
$ 9.86万 - 项目类别:
Understanding the Effects of Chronic Opioids Therapy in Humans
了解慢性阿片类药物治疗对人类的影响
- 批准号:
8509170 - 财政年份:2013
- 资助金额:
$ 9.86万 - 项目类别:
Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
- 批准号:
8691496 - 财政年份:2012
- 资助金额:
$ 9.86万 - 项目类别:
Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
- 批准号:
8431532 - 财政年份:2012
- 资助金额:
$ 9.86万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8240984 - 财政年份:2011
- 资助金额:
$ 9.86万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8451522 - 财政年份:2011
- 资助金额:
$ 9.86万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8041122 - 财政年份:2011
- 资助金额:
$ 9.86万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
7118009 - 财政年份:2004
- 资助金额:
$ 9.86万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
6807970 - 财政年份:2004
- 资助金额:
$ 9.86万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
6918649 - 财政年份:2004
- 资助金额:
$ 9.86万 - 项目类别:
相似国自然基金
Chinese Journal of Integrative Medicine
- 批准号:81224004
- 批准年份:2012
- 资助金额:24.0 万元
- 项目类别:专项基金项目
相似海外基金
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
- 批准号:
2226026 - 财政年份:2024
- 资助金额:
$ 9.86万 - 项目类别:
Cooperative Agreement
Medicine Bundle for Two-Spirit and Indigiqueer Peoples: Expanding and Adapting an Indigenous-Led Sexual Health Testing Program from Colonial British Columbia Across Turtle Island
为两种精神和土著民族提供的药物组合:在海龟岛上扩展和调整不列颠哥伦比亚殖民地的土著主导的性健康测试计划
- 批准号:
487633 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Operating Grants
The Arts as Medicine? New Histories of the Arts and Health
艺术作为医学?
- 批准号:
AH/X008797/1 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Research Grant
Linking Social-Behavior Contextual Factors and Allostatic Load to Chronic Diseases in Diverse Asian Americans: A Socioecological Approach to Advancing Precision Medicine and Health Equity
将社会行为背景因素和稳态负荷与不同亚裔美国人的慢性病联系起来:推进精准医疗和健康公平的社会生态学方法
- 批准号:
10799170 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Evaluating and facilitating the implementation of stepped and measurement-based mental health care in Family Medicine Groups
评估和促进家庭医学小组中阶梯式和基于测量的心理保健的实施
- 批准号:
490034 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Operating Grants
Race, War, and Medicine: The Transdisciplinary Bridge between Asian American Literary Studies and Health/Medical Humanities
种族、战争与医学:亚裔美国文学研究与健康/医学人文学科之间的跨学科桥梁
- 批准号:
23K00403 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
- 批准号:
10704865 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
We Are All Scientists - promotes precision medicine and health research in Indigenous communities through a large scale multimedia campaign and building of strategic partnerships with schools and TCUs
我们都是科学家 - 通过大规模多媒体活动以及与学校和 TCU 建立战略合作伙伴关系,促进原住民社区的精准医学和健康研究
- 批准号:
10912329 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
23 and bee: Molecular medicine for early and effective diagnostics and monitoring of honeybee health
23 和蜜蜂:用于早期有效诊断和监测蜜蜂健康的分子医学
- 批准号:
2879918 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Studentship
Leveraging precision medicine and eHealth to predict cancer predisposition syndromes in children: A Canadian initiative to redress global health disparities in cancer genetics
利用精准医学和电子健康来预测儿童癌症易感综合症:加拿大旨在纠正癌症遗传学方面全球健康差异的一项举措
- 批准号:
479489 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Operating Grants














{{item.name}}会员




